⌘K
Loading ticker…
As of 2026-08-25, Adagio Medical Holdings, Inc Common Stock (ADGM) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 19.3%, relative volume 0.02×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ADGM is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.9% / -39.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ADGM is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $41K notional.
Held by 2 ETFs · $45K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $41K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $5K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADGM Jan avg: 3.79% median: 3.79% win: 50% σ: 10.80% n: 2 2024-08-02 → 2026-07-31 | ADGM Feb avg: -14.42% median: -14.42% win: 0% σ: 20.39% n: 2 2024-08-02 → 2026-07-31 | ADGM Mar avg: 5.84% median: 5.84% win: 50% σ: 12.96% n: 2 2024-08-02 → 2026-07-31 | ADGM Apr avg: 19.28% median: 19.28% win: 50% σ: 57.97% n: 2 2024-08-02 → 2026-07-31 | ADGM May avg: -15.99% median: -15.99% win: 0% σ: 5.08% n: 2 2024-08-02 → 2026-07-31 | ADGM Jun avg: 2.52% median: 2.52% win: 50% σ: 17.71% n: 2 2024-08-02 → 2026-07-31 | ADGM Jul avg: -20.20% median: -20.20% win: 50% σ: 30.75% n: 2 2024-08-02 → 2026-07-31 | ADGM Aug avg: -10.56% median: -10.56% win: 50% σ: 46.01% n: 2 2024-08-02 → 2026-07-31 (current) | ADGM Sep avg: -14.70% median: -14.70% win: 50% σ: 49.78% n: 2 2024-08-02 → 2026-07-31 | ADGM Oct avg: -18.29% median: -18.29% win: 50% σ: 32.45% n: 2 2024-08-02 → 2026-07-31 | ADGM Nov avg: -15.38% median: -15.38% win: 0% σ: 20.17% n: 2 2024-08-02 → 2026-07-31 | ADGM Dec avg: -15.51% median: -15.51% win: 50% σ: 63.88% n: 2 2024-08-02 → 2026-07-31 |